Seminars in Radiation Oncology

Papers
(The TQCC of Seminars in Radiation Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Biology of Radiation-Induced Lung Injury39
Epidemiology of HPV Related Malignancies35
Biology of HPV Mediated Carcinogenesis and Tumor Progression31
The Radiobiology of Radiopharmaceuticals29
The Role of Theranostics in Prostate Cancer22
Quality Assurance for AI-Based Applications in Radiation Therapy21
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology19
Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy18
Regulatory Aspects of the Use of Artificial Intelligence Medical Software18
Automated Tumor Segmentation in Radiotherapy17
Radiopharmaceutical Chemistry and Drug Development—What's Changed?16
Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients16
Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies15
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations15
Uncertainty Assessment for Deep Learning Radiotherapy Applications15
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets15
Prevention and Screening of HPV Malignancies15
The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade14
Radiopharmaceuticals for Neuroendocrine Tumors14
Chromosome Missegregation as a Modulator of Radiation Sensitivity13
Artificial Intelligence for Image Registration in Radiation Oncology13
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity12
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer12
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations12
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC11
Imaging and its Impact on Defining the Oligometastatic State11
Theranostics: The Role of Quantitative Nuclear Medicine Imaging11
Artificial Intelligence for Outcome Modeling in Radiotherapy10
Advances in Automated Treatment Planning10
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers9
Novel Agents and Future Perspectives on Theranostics9
The Biological Process of Aging and the Impact of Ionizing Radiation9
Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date9
DCIS: Risk Assessment in the Molecular Era8
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer8
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials8
Potential of Deep Learning in Quantitative Magnetic Resonance Imaging for Personalized Radiotherapy7
Radiopharmaceuticals for Bone Metastases7
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer7
Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials7
The Spectrum of Metastasis: An Opportunity for Cure?7
Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology7
Mechanisms of Immune Modulation by Radiation7
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC6
Immunotherapy for HPV Malignancies6
Seeing is Believing: State of the Art Imaging of Bladder Cancer6
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm6
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence6
Radiation Therapy in the Management of Adrenal Metastases6
The Promise and Future of Radiomics for Personalized Radiotherapy Dosing and Adaptation6
Artificial Intelligence and Deep Learning for Brachytherapy6
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology6
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape6
Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology6
Radiation and Modulation of the Tumor Immune Microenvironment in Non–Small Cell Lung Cancer6
0.028653144836426